Glooko is a healthcare technology company which offers a diabetes management platform to healthcare providers, patients, and pharmaceutical companies. The platform is designed to integrate with hundreds of diabetes devices to gather and analyze patient data. Through comprehensive data centralization and analytical tools, Glooko aims to enhance diabetes management and facilitate clinical research in the field. This company was founded by Yogen Dalal, Sundeep Madra, and Chamath Palihapitiya in 2010 and is headquartered in Palo Alto, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/10/2024 | Series F | $100MM | $xx.xx | $475.64MM | Georgian Partners, Health Catalyst Capital, Canaan | |
Price per Share
$xx.xx
Shares Outstanding
41,407,867
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Georgian Partners, Health Catalyst Capital, Canaan
|
||||||
08/18/2023 | Series E-Prime | $30.56MM | $xx.xx | $318.34MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
12,652,982
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
08/18/2023 | Series E | $30.56MM | $xx.xx | $318.34MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
12,652,982
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
03/16/2021 | Series D-Prime | $10MM | $xx.xx | $150.67MM | Health Catalyst Capital, Canaan Partners, Georgian, Novo Nordisk, Insulet, Mayo Clinic | |
Price per Share
$xx.xx
Shares Outstanding
7,510,886
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Health Catalyst Capital, Canaan Partners, Georgian, Novo Nordisk, Insulet, Mayo Clinic
|
||||||
03/16/2021 | Series D | $20MM | $xx.xx | $150.67MM | Health Catalyst Capital, Canaan Partners, Georgian, Novo Nordisk, Insulet, Mayo Clinic | |
Price per Share
$xx.xx
Shares Outstanding
15,021,772
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Health Catalyst Capital, Canaan Partners, Georgian, Novo Nordisk, Insulet, Mayo Clinic
|
||||||
06/27/2017 | Series C-1-Prime | $13.01MM | $xx.xx | $116.76MM | Georgian Partners, Insulet, Mayo Clinic, Canaan Partners, Social Capital, Medtronic, Samsung | |
Price per Share
$xx.xx
Shares Outstanding
10,335,930
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Georgian Partners, Insulet, Mayo Clinic, Canaan Partners, Social Capital, Medtronic, Samsung
|
||||||
06/27/2017 | Series C-1 | $13.29MM | $xx.xx | $116.76MM | Georgian Partners, Insulet, Mayo Clinic, Canaan Partners, Social Capital, Medtronic, Samsung | |
Price per Share
$xx.xx
Shares Outstanding
10,562,032
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Georgian Partners, Insulet, Mayo Clinic, Canaan Partners, Social Capital, Medtronic, Samsung
|
||||||
09/17/2016 | Series C-Prime | $8.35MM | $xx.xx | $135.3MM | Canaan Partners, Social Capital, Samsung, Yogen Dalal | |
Price per Share
$xx.xx
Shares Outstanding
4,130,876
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.1x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Canaan Partners, Social Capital, Samsung, Yogen Dalal
|
||||||
09/17/2016 | Series C | $8.35MM | $xx.xx | $135.3MM | Canaan Partners, Social Capital, Samsung, Yogen Dalal | |
Price per Share
$xx.xx
Shares Outstanding
4,130,876
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Canaan Partners, Social Capital, Samsung, Yogen Dalal
|
||||||
03/17/2015 | Series B-Prime | $8.25MM | $xx.xx | $85.02MM | Medtronic, Canaan Partners, Social Capital, Samsung | |
Price per Share
$xx.xx
Shares Outstanding
6,061,808
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Medtronic, Canaan Partners, Social Capital, Samsung
|
||||||
03/17/2015 | Series B | $8.25MM | $xx.xx | $85.02MM | Medtronic, Canaan Partners, Social Capital, Samsung | |
Price per Share
$xx.xx
Shares Outstanding
6,061,808
Liquidation Pref Order
6
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Medtronic, Canaan Partners, Social Capital, Samsung
|
||||||
01/08/2014 | Series A-1-Prime | $3.5MM | $xx.xx | $25.22MM | Samsung, Lifeforce Ventures, Social Capital, Sundeep Madra, Yogen Dalal | |
Price per Share
$xx.xx
Shares Outstanding
4,504,968
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Samsung, Lifeforce Ventures, Social Capital, Sundeep Madra, Yogen Dalal
|
||||||
01/08/2014 | Series A-1 | $3.5MM | $xx.xx | $25.22MM | Samsung, Lifeforce Ventures, Social Capital, Sundeep Madra, Yogen Dalal | |
Price per Share
$xx.xx
Shares Outstanding
4,504,968
Liquidation Pref Order
7
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Samsung, Lifeforce Ventures, Social Capital, Sundeep Madra, Yogen Dalal
|
||||||
01/30/2012 | Series A-Prime | $1.15MM | $xx.xx | $29.2MM | Social Capital, Bill Campbell, Vint Cerf, Judy Estrin, Andy Hertzfeld, Venky Harinarayan, Russell Hirsch, Xtreme Labs | |
Price per Share
$xx.xx
Shares Outstanding
115,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
5.6x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Social Capital, Bill Campbell, Vint Cerf, Judy Estrin, Andy Hertzfeld, Venky Harinarayan, Russell Hirsch, Xtreme Labs
|
||||||
01/30/2012 | Series A | $1.15MM | $xx.xx | $29.2MM | Social Capital, Bill Campbell, Vint Cerf, Judy Estrin, Andy Hertzfeld, Venky Harinarayan, Russell Hirsch, Xtreme Labs | |
Price per Share
$xx.xx
Shares Outstanding
115,000
Liquidation Pref Order
8
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
5.6x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Social Capital, Bill Campbell, Vint Cerf, Judy Estrin, Andy Hertzfeld, Venky Harinarayan, Russell Hirsch, Xtreme Labs
|
||||||
11/09/2011 | Series Seed-Prime | $500,000 | $xx.xx | $5MM | Social Capital, Bill Campbell, Vint Cerf, Andy Hertzfeld, Judy Estrin, Anand Agarawala, Venky Harinarayan and Annad Rajaraman, Russel Hirsch, Xtreme Labs | |
Price per Share
$xx.xx
Shares Outstanding
250,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
2.1x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Social Capital, Bill Campbell, Vint Cerf, Andy Hertzfeld, Judy Estrin, Anand Agarawala, Venky Harinarayan and Annad Rajaraman, Russel Hirsch, Xtreme Labs
|
||||||
11/09/2011 | Series Seed | $500,000 | $xx.xx | $5MM | Social Capital, Bill Campbell, Vint Cerf, Andy Hertzfeld, Judy Estrin, Anand Agarawala, Venky Harinarayan and Annad Rajaraman, Russel Hirsch, Xtreme Labs | |
Price per Share
$xx.xx
Shares Outstanding
250,000
Liquidation Pref Order
8
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
2.1x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Social Capital, Bill Campbell, Vint Cerf, Andy Hertzfeld, Judy Estrin, Anand Agarawala, Venky Harinarayan and Annad Rajaraman, Russel Hirsch, Xtreme Labs
|